NasdaqGS - Nasdaq Real Time Price USD
Inozyme Pharma, Inc. (INZY)
3.9900
+0.0400
+(1.01%)
At close: 4:00:01 PM EDT
3.9797
-0.01
(-0.26%)
After hours: 6:32:18 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -0.32 | -0.27 | -1.24 | -0.98 |
| Low Estimate | -0.36 | -0.33 | -1.43 | -1.25 |
| High Estimate | -0.29 | -0.23 | -1.13 | -0.76 |
| Year Ago EPS | -0.44 | -0.39 | -1.62 | -1.24 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 6 | 6 |
| Avg. Estimate | -- | -- | -- | 1.24M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 7.41M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.35 | -0.43 | -0.37 | -0.4 |
| EPS Actual | -0.44 | -0.39 | -0.42 | -0.44 |
| Difference | -0.09 | 0.04 | -0.05 | -0.04 |
| Surprise % | -23.94% | 9.83% | -12.50% | -10.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.32 | -0.27 | -1.24 | -0.98 |
| 7 Days Ago | -0.23 | -0.23 | -1.11 | -1.09 |
| 30 Days Ago | -0.23 | -0.23 | -1.11 | -1.36 |
| 60 Days Ago | -0.23 | -0.23 | -1.11 | -1.36 |
| 90 Days Ago | 0 | 0 | -1.5 | -1.59 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | -- | 1 |
| Up Last 30 Days | -- | 1 | 2 | 1 |
| Down Last 7 Days | 1 | -- | 1 | -- |
| Down Last 30 Days | 1 | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| INZY | 27.27% | 30.77% | 23.46% | 21.24% |
| S&P 500 | 13.32% | 2.67% | 7.78% | 13.75% |
Upgrades & Downgrades
| Downgrade | Wells Fargo: Overweight to Equal-Weight | 5/16/2025 |
| Downgrade | Jefferies: Buy to Hold | 5/16/2025 |
| Downgrade | Needham: Buy to Hold | 5/16/2025 |
| Maintains | Needham: Buy to Buy | 5/14/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/10/2025 |
| Reiterates | Needham: Buy to Buy | 4/8/2025 |
Related Tickers
AFMD Affimed N.V.
0.1815
-34.95%
HCWB HCW Biologics Inc.
8.57
-4.25%
CNSP CNS Pharmaceuticals, Inc.
1.2900
+0.78%
KLTO Klotho Neurosciences, Inc.
0.2310
+2.85%
CTMX CytomX Therapeutics, Inc.
2.1300
+4.93%
XLO Xilio Therapeutics, Inc.
0.8800
+2.40%
CABA Cabaletta Bio, Inc.
1.9200
-5.42%
SEPN Septerna, Inc.
9.97
+1.32%
ABP Abpro Corporation
0.2720
+18.26%
NCNA NuCana plc
0.0482
+10.05%